Actively Recruiting
Timing of LNG-IUD Insertion and Ovarian Cyst Formation
Led by Gaziosmanpasa Research and Education Hospital · Updated on 2025-11-25
60
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this prospective observational study, the effect of timing of insertion (early/late follicular; early/late luteal) on ovarian cyst development in women receiving an LNG-IUD will be assessed ultrasonographically at months 0, 3, 6, and 12. Secondary outcomes include cyst size/structure, bleeding pattern, pain, and other adverse events.
CONDITIONS
Official Title
Timing of LNG-IUD Insertion and Ovarian Cyst Formation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 18 to 45 years
- Indicated for LNG-IUD insertion due to abnormal uterine bleeding, menorrhagia, dysmenorrhea, endometriosis, adenomyosis, hormonally induced dysfunctional uterine bleeding, endometrial protection during hormone therapy, or endouterine hyperplasia without atypia
- No contraindications for LNG-IUD including no suspected pregnancy, no serious uterine anomalies, no active pelvic infection, no serious liver disease or breast cancer, and no barriers to IUD insertion
- No use of oral contraceptives for at least 3 months prior
- Previous IUD removal at least 1 year before
- Signed informed consent and voluntary participation
- No use of steroidal anti-inflammatory drugs within 24 hours before LNG-IUD insertion
You will not qualify if you...
- Current or past pregnancy
- Use of hormone therapy
- Presence of adnexal masses
- Severe systemic diseases such as uncontrolled diabetes, advanced cardiovascular disease, active malignancies, advanced liver or kidney failure, or systemic connective tissue diseases
- Contraindications to LNG-IUD including suspected pregnancy, severe uterine anomalies, active pelvic infection, severe liver disease, history of breast cancer, or anatomical/clinical obstacles to IUD insertion
- Psychological disabilities
- Refusal to sign informed consent
- Inability to complete follow-up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
SBÜ Gaziosmanpaşa Training and Research Hospital
Gaziosmanpaşa, Outside of the US, Turkey (Türkiye), 33400
Actively Recruiting
Research Team
E
ecenur çelikoğlu, md
CONTACT
Y
yağmur acıyiyen, md
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here